First UK shipment of solid state batteries targets wearables

First UK shipment of solid state batteries targets wearables

Business news |
By Nick Flaherty

Ilika has made the first customer shipments of its Stereax solid state batteries from its UK manufacturing plant.

This shipment is the first of a series of planned deliveries and consists of a batch of single layer Stereax M50 cells to Israeli wearables Blink Energy.

The M50 cells can be used individually, but they are also the building blocks for Ilika’s M300 batteries, which are constructed from six M50 cells connected in parallel. Forthcoming Stereax customer deliveries will also include M300 batteries.

Blink is using the ultra-thin M50 cells to power its smart wearable patch, This fits onto the eyelid epicanthal fold and contains a designated power and communication platform that wirelessly connects a smart lens to a mobile app.

“We are delighted to have begun fulfilling our commitments to customers by shipping batteries from our UK facility. Starting with Blink Energy, we look forward to further supporting our customers’ product roadmaps for miniature medical devices and industrial IoT applications. Our relationship with Cirtec will further support commercial ramp-up in due course,” said Graeme Purdy, Ilika’s Chief Executive Officer.

Yariv Bar-on, Blink Energy co-founder and Chief Executive Officer, commented: “We are looking forward with great anticipation to the arrival of the first batch of Ilika’s Stereax cells. These are miniature batteries that offer the optimal form factor and power density necessary to power and facilitate communication for Blink’s platform of smart ocular devices. As we continue to develop our product offerings, we eagerly anticipate evaluating the Stereax cells to determine their potential impact.”

Ilika is also finalising its partnership with Cirtec in the US to transfer of Stereax mm-scale battery manufacturing to Cirtec’s facility in Lowell, Massachusetts. Following the transfer, Ilika will focus on advanced technology development and IP licensing in support of Cirtec’s manufacturing and commercialisation activities.;

Related articles

If you enjoyed this article, you will like the following ones: don't miss them by subscribing to :    eeNews on Google News


Linked Articles